Bivalirudin use during percutaneous coronary intervention in patients on chronic warfarin therapy

Thrombosis Research

Volumn 133, Issue 4, 2014, Pages 695-696

  Kiviniemi, Tuomas ^a   Karjalainen, Pasi ^b   Niemelä, Matti ^c   Rubboli, Andrea ^d   Lip, Gregory Y H ^e   Schlitt, Axel ^f   Nammas, Wail ^a   Airaksinen, K E Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d MAGGIORE HOSPITAL   (Italy)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRULOG; WARFARIN; BIVALIRUDIN; GLYCOPROTEIN P INHIBITOR; ANTICOAGULANT AGENT; ANTITHROMBIN; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; BLEEDING; CEREBROVASCULAR DISEASE; EUROPE; FINLAND; HUMAN; INFORMATION PROCESSING; INTERNATIONAL NORMALIZED RATIO; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THROMBOSIS; TREATMENT INDICATION; ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS GRAFT; DRUG USE; HEART DISEASE; HEART INFARCTION; LONG TERM CARE; LUNG EMBOLISM; STENT THROMBOSIS; TARGET VESSEL REVASCULARIZATION; AGED; FEMALE; MALE; MIDDLE AGED;

AGED; ANTICOAGULANTS; ANTITHROMBINS; FEMALE; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; RECOMBINANT PROTEINS; WARFARIN;

EID: 84896130369     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.01.038     Document Type: Letter

References (11)

1. G.Y.H. Lip, K. Huber, and F. Andreotti et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: Executive summary - a consensus document of the european society of cardiology working group on thrombosis, endorsed by the european heart rhythm association (EHRA) and the european association of percutaneous cardiovascular interventions (EAPCI) Eur Heart J 31 11 2010 1311 1318
2. A. Kastrati, F. Neumann, and J. Mehilli et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 7 2008 688 696
3. G.W. Stone, B. Witzenbichler, and G. Guagliumi et al. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 21 2008 2218 2230
4. P.P. Karjalainen, S. Vikman, and M. Niemelä et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment Eur Heart J 29 8 2008 1001 1010
5. H. Lahtela, P.P. Karjalainen, and M. Niemelä et al. Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment? Thromb Haemost 102 6 2009 1227 1233
6. T. Kiviniemi, P. Karjalainen, and M. Pietilä et al. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention Am J Cardiol 110 1 2012 30 35
7. A.K. Rao, C. Pratt, and A. Berke et al. Thrombolysis in myocardial infarction (TIMI) trial - Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1 1988 1 11
8. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials Circulation 115 17 2007 2344 2351
9. S. Subherwal, E.D. Peterson, and A.Y. Chen et al. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among Non-ST-Segment-Elevation myocardial infarction patients on home warfarin therapy / clinical perspective Circulation 125 11 2012 1414 1423
10. J.D. Douketis, P.B. Berger, and A.S. Dunn et al. The perioperative management of antithrombotic Therapy*American college of chest physicians evidence-based clinical practice guidelines 8th ed. Chest 133(6-suppl) 2008 299S 339S
11. K. Airaksinen, A. Schlitt, A. Rubboli, P. Karjalainen, and G.Y. Lip How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: To "bridge" or not to "bridge"? EuroIntervention 6 4 2011 520 526